XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
  Cornea
  Cataract
  Retina
   ARMD
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

ARMD Channel
subscribe to ARMD newsletter

Latest Research : Ophthalmology : Retina : ARMD

   DISCUSS   |   EMAIL   |   PRINT
Gene Variation implicated for Age-Related Macular Degeneration (ARMD)
Mar 11, 2005, 16:28, Reviewed by: Dr.

"By finding genes, we can understand where the biological pathways are and the processes involved in the disease. Once we determine which genes are responsible for macular degeneration, we can screen the population and manipulate biological pathways to develop treatments."

 
Half of all cases of age-related macular degeneration, the leading cause of blindness among the elderly, could be caused by a variation in a particular gene, according to UT Southwestern Medical Center researchers involved in a multicenter study.

The National Eye Institute study - which will appear in an upcoming edition of the journal Science and is available online - links a mutation in the gene Complement Factor H to an increased risk of age-related macular degeneration (AMD).

Macular degeneration is a complex disease that is the leading cause of blindness in Americans over the age of 50. By age 75, an estimated 30 percent of Americans have some manifestation of AMD.

The macula is an area in the center of the retina where light is focused and changed into nerve signals to compose an image in the brain. This central or "macular" vision enables us to read, drive and do things requiring fine, sharp, straight-ahead vision.

"We've identified a gene that is implicated in the pathogenesis of AMD," said Robert Ritter, a UT Southwestern research scientist involved in the Science study. "It provides a starting point for future investigations that will help us understand what takes place during the breakdown of the visual process."

Scientists have long suspected a genetic role in the disease but previously were only able to narrow the culprit gene's location to one region of a particular chromosome.

"We know that one of the most significant factors in determining who gets macular degeneration is family history," said Dr. Albert Edwards, the study's lead author and an assistant professor of ophthalmology at UT Southwestern when he conducted his research. "A positive family history can increase a person's chances of developing macular degeneration several fold compared to people in the general population."

In the study, researchers analyzed genetic data from more than 200 patients who were at high risk for developing AMD or who already had AMD in one or both eyes, and from more than 130 healthy participants without a known family history of the disease. The genetic mutation of Complement Factor H was present in half of those with AMD or at high risk for the disease.

Researchers from the UT Southwestern Eugene McDermott Center for Human Growth and Development provided genotyping, technical advice and assistance.

"This is an important study that gives us new insight into a disease that impacts a growing population of aging Americans," said Dr. Helen Hobbs, director of the center and chief of Clinical Genetics at UT Southwestern. "Genetic studies such as this provide the basis for clinicians to identify those at risk and may lead to better treatment options."

These findings may help researchers develop new preventive and therapeutic strategies for managing AMD.

"By finding genes, we can understand where the biological pathways are and the processes involved in the disease," said Dr. Edwards, who is now the president of the Institute for Retina Research at Presbyterian Hospital of Dallas. "Once we determine which genes are responsible for macular degeneration, we can screen the population and manipulate biological pathways to develop treatments."
 

- The National Eye Institute study will appear in an upcoming edition of the journal Science and is available online
 

www.utsouthwestern.edu

 
Subscribe to ARMD Newsletter
E-mail Address:

 

Also involved in the study were researchers from Boston University School of Medicine and Sequenom, Inc.

The study was funded by an unrestricted grant from Research to Prevent Blindness in addition to the NEI, which is part of the National Institutes of Health.


Related ARMD News

Yellow plant pigments lutein and zeaxanthin reduce risk of age-related macular degeneration
Hormone Therapy Does Not Affect Age-Related Vision Loss
Eating Fish Protects Against Macular Degeneration
Research Highlights Risk Factors For Age-Related Vision Loss
FDA approves ranibizumab for the treatment of wet age-related macular degeneration
High Body Mass Index Increase the Genetic Risk of AMD
Ranibizumab Approved for Wet Age-Related Macular Degeneration
New genetic discovery explains 74 percent cases of age-related macular degeneration
Just two genes, Factor H and Factor B, cause blindness in millions
Antioxidants reduce risk of age-related macular degeneration


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us